Covid-19 roundup: CureVac expands cache to $1.3B as coronavirus race heats up; Russian scientists publish early data to back up vaccine
The money just keeps on pouring in for CureVac.
Following a series of high-profile deals and an IPO raise totaling nearly $1 billion in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
